JAMA Internal Medicine

OCTOBER 6, 2024

This crossover randomized clinical trial aims to determine the effect of different arm positions on blood pressure readings.

Clinical Trials 111

Clinical Trials Clinical Trials Trials 111

pharmaphorum

OCTOBER 6, 2024

Recent financings in the digital health sector include a $73 million round for artificial intelligence-enabled robotics player Mendaera, with Qure.ai, VieCure, Rippl, and Univa Health also raising money.Silicon Valley startup Mendaera has earmarked the Series B funding to complete the development of its handheld robotics, medical imaging and AI platform, which is intended for use in commonplace medical procedures like taking biopsies, organ and vascular access, and pain management.

Development 91

Development 91

JAMA Internal Medicine

OCTOBER 6, 2024

This randomized clinical trial examines the effect of a benzodiazepine taper plus augmented cognitive behavioral therapy for insomnia program vs an unmasked taper plus standard cognitive behavioral therapy for insomnia.

Clinical Trials 59

Clinical Trials Clinical Trials Trials 59

pharmaphorum

OCTOBER 6, 2024

Activist investor Starboard Value has amassed a $1bn stake in pharma group Pfizer and wants strategic changes to restore growth

64

64

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Drug Patent Watch

OCTOBER 6, 2024

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … Source

Drugs 52

Drugs 52